Petros Katsogiannos
Overview
Explore the profile of Petros Katsogiannos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Randell E, Katsogiannos P, Leksell J, Eriksson J, Sundbom M, Engstrom M
Clin Obes
. 2023 Jul;
13(5):e12610.
PMID: 37431181
Bariatric surgery is the most medically and cost-effective treatment for adults with obesity and type 2 diabetes mellitus (T2DM). Our findings suggest initial improvements in health-related quality of life that...
2.
Fanni G, Katsogiannos P, Nandi Jui B, Sundbom M, Hetty S, Pereira M, et al.
Endocr Connect
. 2022 Jul;
11(8).
PMID: 35904227
Purpose: In patients with type 2 diabetes mellitus (T2DM), Roux-en-Y gastric bypass (RYGB) leads to beneficial metabolic adaptations, including enhanced incretin secretion, beta-cell function, and systemic insulin sensitivity. We explored...
3.
Almby K, Katsogiannos P, Pereira M, Anders Karlsson F, Sundbom M, Wiklund U, et al.
J Clin Endocrinol Metab
. 2021 Jun;
106(10):e4049-e4061.
PMID: 34086911
Context: Roux-en-Y gastric bypass surgery (RYGB) markedly improves glycemia in patients with type 2 diabetes (T2D), but underlying mechanisms and changes over time are incompletely understood. Objective: Integrated assessment of...
4.
Eriksson J, Visvanathar R, Kullberg J, Strand R, Skrtic S, Ekstrom S, et al.
Eur J Endocrinol
. 2021 Apr;
184(6):879-889.
PMID: 33852422
Objective: To obtain direct quantifications of glucose turnover, volumes and fat content of several tissues in the development of type 2 diabetes (T2D) using a novel integrated approach for whole-body...
5.
Katsogiannos P, Kamble P, Pereira M, Sundbom M, Carlsson P, Eriksson J, et al.
Obesity (Silver Spring)
. 2021 Feb;
29(3):535-542.
PMID: 33624436
Objective: This study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months after Roux-en-Y gastric bypass...
6.
Katsogiannos P, Randell E, Sundbom M, Rosenblad A, Eriksson J, Leksell J
Diabetol Metab Syndr
. 2020 Oct;
12:90.
PMID: 33062061
Background: To examine the effects of gastric bypass surgery on health-related quality of life (HRQoL) in obese patients with type 2 diabetes, and to investigate their experiences of life adjustments...
7.
Ahmed F, Sarsenbayeva A, Katsogiannos P, Aguer C, Pereira M
Toxicology
. 2020 Sep;
445:152600.
PMID: 32976960
Purpose: The environmental endocrine disruptors, bisphenol A (BPA) and bisphenol S (BPS) are associated with the development of type 2 diabetes. We aim to study the effects of BPA or...
8.
Sjoholm A, Pereira M, Nilsson T, Linde T, Katsogiannos P, Saaf J, et al.
Lakartidningen
. 2020 Sep;
117.
PMID: 32969484
Type B insulin resistance syndrome (TBIRS) is a very rare autoimmune condition with polyclonal autoantibodies directed against the insulin receptor, which results in severe and refractory hyperglycemia and high mortality....
9.
Sjoholm A, Pereira M, Nilsson T, Linde T, Katsogiannos P, Saaf J, et al.
Endocrinol Diabetes Metab Case Rep
. 2020 Jun;
2020.
PMID: 32478674
Summary: Type B insulin resistance syndrome (TBIRS) is a very rare autoimmune disorder with polyclonal autoantibodies against the insulin receptor, resulting in severe and refractory hyperglycemia. Described here is a...
10.
Katsogiannos P, Kamble P, Wiklund U, Sundbom M, Espes D, Hammar U, et al.
Endocrine
. 2020 Jan;
67(2):344-353.
PMID: 31983031
Objective: To explore the role of hormones and the autonomic nervous system in the rapid remission of diabetes after Roux-en-Y Gastric Bypass (RYGB). Research Design And Methods: Nineteen obese patients...